pI: 4.659 |
Length (AA): 931 |
MW (Da): 106258 |
Paralog Number:
3
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128602)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_51465 | alpha-actinin |
Caenorhabditis elegans | CELE_W04D2.1 | Protein ATN-1, isoform C |
Dictyostelium discoideum | DDB_G0268632 | actin binding protein A |
Drosophila melanogaster | Dmel_CG4376 | alpha actinin |
Echinococcus granulosus | EgrG_001096300 | alpha actinin sarcomeric |
Echinococcus granulosus | EgrG_000856100 | alpha actinin sarcomeric |
Entamoeba histolytica | EHI_199000 | calponin homology domain protein, putative |
Echinococcus multilocularis | EmuJ_000856100 | alpha actinin, sarcomeric |
Echinococcus multilocularis | EmuJ_001096300 | alpha actinin, sarcomeric |
Homo sapiens | ENSG00000072110 | actinin, alpha 1 |
Homo sapiens | 81 | actinin, alpha 4 |
Homo sapiens | ENSG00000077522 | actinin, alpha 2 |
Loa Loa (eye worm) | LOAG_08734 | alpha-actinin |
Loa Loa (eye worm) | LOAG_10741 | hypothetical protein |
Mus musculus | ENSMUSG00000052374 | actinin alpha 2 |
Mus musculus | ENSMUSG00000015143 | actinin, alpha 1 |
Mus musculus | ENSMUSG00000054808 | actinin alpha 4 |
Mus musculus | ENSMUSG00000006457 | actinin alpha 3 |
Schistosoma japonicum | Sjp_0086910 | ko:K05699 actinin alpha, putative |
Schistosoma japonicum | Sjp_0118260 | Alpha-actinin, sarcomeric, putative |
Schistosoma japonicum | Sjp_0059270 | Alpha-actinin-1, putative |
Schistosoma japonicum | Sjp_0310450 | Alpha-actinin, sarcomeric, putative |
Schistosoma japonicum | Sjp_0105890 | Alpha-actinin, sarcomeric, putative |
Schistosoma mansoni | Smp_034550 | alpha-actinin |
Schistosoma mansoni | Smp_014780.1 | alpha-actinin |
Schistosoma mansoni | Smp_014780.2 | alpha-actinin |
Schmidtea mediterranea | mk4.013143.01 | |
Schmidtea mediterranea | mk4.011730.00 | |
Schmidtea mediterranea | mk4.008854.00 | |
Schmidtea mediterranea | mk4.004376.00 | |
Schmidtea mediterranea | mk4.006136.00 | |
Schmidtea mediterranea | mk4.015134.00 | |
Schmidtea mediterranea | mk4.012882.00 | |
Schmidtea mediterranea | mk4.002344.00 | |
Schmidtea mediterranea | mk4.005366.02 | |
Schmidtea mediterranea | mk4.032913.00 | |
Schmidtea mediterranea | mk4.008854.01 | |
Schmidtea mediterranea | mk4.027393.01 | |
Schmidtea mediterranea | mk4.018845.00 | |
Schmidtea mediterranea | mk4.018281.00 | |
Schmidtea mediterranea | mk4.027393.00 | |
Schmidtea mediterranea | mk4.012882.01 | |
Trichomonas vaginalis | TVAG_239310 | bollus pemphigoid antigen, putative |
Trichomonas vaginalis | TVAG_190450 | kakapo, putative |
Trichomonas vaginalis | TVAG_190470 | hypothetical protein |
Trichomonas vaginalis | TVAG_156680 | vab10 spectraplakin, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_W04D2.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bos taurus | Calmodulin | 149 aa | 24.0% | 121 aa | Compounds | References |